New Lp(a) lowering drug

Nick1 September 5, 2026, 10:33pm 256

Lipoprotein a Phase 3 Trial results - Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal General

Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal The Phase 3 study found a drug didn’t reduce the risk of cardiovascular events such as heart attacks and strokes https://www.wsj.com/health/pharma/novartis-says-closely-watched-cholesterol-study-failed-to-meet-goal-7901cb11?mod=mhp

3 Likes

show post in topic

Home
Categories
Guidelines
Terms of Service
Privacy Policy

Powered by Discourse, best viewed with JavaScript enabled